JP2017214420A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017214420A5 JP2017214420A5 JP2017159116A JP2017159116A JP2017214420A5 JP 2017214420 A5 JP2017214420 A5 JP 2017214420A5 JP 2017159116 A JP2017159116 A JP 2017159116A JP 2017159116 A JP2017159116 A JP 2017159116A JP 2017214420 A5 JP2017214420 A5 JP 2017214420A5
- Authority
- JP
- Japan
- Prior art keywords
- tumor
- composition
- dash inhibitor
- group
- cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161562497P | 2011-11-22 | 2011-11-22 | |
| US61/562,497 | 2011-11-22 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014543501A Division JP6240083B2 (ja) | 2011-11-22 | 2012-11-15 | 樹状細胞癌ワクチンのための小分子エンハンサー |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2017214420A JP2017214420A (ja) | 2017-12-07 |
| JP2017214420A5 true JP2017214420A5 (https=) | 2018-02-08 |
Family
ID=48470210
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014543501A Active JP6240083B2 (ja) | 2011-11-22 | 2012-11-15 | 樹状細胞癌ワクチンのための小分子エンハンサー |
| JP2017159116A Pending JP2017214420A (ja) | 2011-11-22 | 2017-08-22 | 樹状細胞癌ワクチンのための小分子エンハンサー |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014543501A Active JP6240083B2 (ja) | 2011-11-22 | 2012-11-15 | 樹状細胞癌ワクチンのための小分子エンハンサー |
Country Status (9)
| Country | Link |
|---|---|
| US (3) | US9284337B2 (https=) |
| EP (2) | EP2782994B1 (https=) |
| JP (2) | JP6240083B2 (https=) |
| CN (2) | CN104039952A (https=) |
| AU (2) | AU2012340887A1 (https=) |
| CA (1) | CA2856379A1 (https=) |
| HK (1) | HK1201871A1 (https=) |
| IL (1) | IL232664A0 (https=) |
| WO (1) | WO2013078059A1 (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104039952A (zh) * | 2011-11-22 | 2014-09-10 | 塔夫茨大学信托人 | 用于树突状细胞癌症疫苗的小分子增强剂 |
| EP3224263B1 (en) | 2014-11-25 | 2023-05-17 | BioXcel LLC | Use of ubiquitin-proteasome system inhibitors for treatment of tumors associated with neurofibromatosis type-2 |
| CN116059219A (zh) * | 2015-07-16 | 2023-05-05 | 比奥克斯塞尔医疗股份有限公司 | 一种使用免疫调节治疗癌症的新颖方法 |
| WO2017020974A1 (en) * | 2015-08-03 | 2017-02-09 | Institut Pasteur | Dipeptidylpeptidase 4 inhibition enhances lymphocyte trafficking, improving both naturally occurring tumor immunity and immunotherapy |
| WO2018049014A1 (en) * | 2016-09-07 | 2018-03-15 | Trustees Of Tufts College | Dash inhibitors, and uses related thereto |
| ES2928773T3 (es) | 2017-01-17 | 2022-11-22 | Heparegenix Gmbh | Inhibidores de proteína cinasas para fomentar la regeneración hepática o reducir o prevenir la muerte de hepatocitos |
| WO2018187698A2 (en) * | 2017-04-07 | 2018-10-11 | Trustees Of Tufts College | Combination therapies using caspase-1 dependent anticancer agents and pge2 antagonists |
| US11559537B2 (en) | 2017-04-07 | 2023-01-24 | Trustees Of Tufts College | Combination therapies using caspase-1 dependent anticancer agents and PGE2 antagonists |
| JP2019208422A (ja) * | 2018-06-04 | 2019-12-12 | コリア・インスティテュート・オブ・サイエンス・アンド・テクノロジー | ヒアルロニダーゼを含む新規な組換えエキソソーム及びその用途 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6040145A (en) * | 1997-05-07 | 2000-03-21 | Tufts University | Potentiation of the immune response |
| EP1104293A1 (en) | 1998-08-21 | 2001-06-06 | Point Therapeutics, Inc. | Regulation of substrate activity |
| EP1187619A1 (en) * | 1999-05-25 | 2002-03-20 | Point Therapeutics, Inc. | Anti-tumor agents comprising boroproline compounds |
| US7135575B2 (en) * | 2003-03-03 | 2006-11-14 | Array Biopharma, Inc. | P38 inhibitors and methods of use thereof |
| CN100392074C (zh) * | 2003-10-15 | 2008-06-04 | 上海海欣生物技术有限公司 | 树突状细胞肿瘤疫苗及其制法和用途 |
| KR20080030079A (ko) * | 2005-07-05 | 2008-04-03 | 트러스티즈 오브 터프츠 칼리지 | 섬유아세포 활성 단백질 알파의 억제제 |
| WO2007100374A2 (en) * | 2005-12-19 | 2007-09-07 | Trustees Of Tufts College | Soft protease inhibitors and pro-soft forms thereof |
| WO2007123686A2 (en) * | 2006-03-31 | 2007-11-01 | Point Therapeutics, Inc. | Dpp inhibitors and uses thereof |
| WO2008116054A1 (en) * | 2007-03-20 | 2008-09-25 | Trustees Of Tufts College | Inhibitors of fibroblast activation protein, and methods of use thereof |
| EP2154243B1 (en) * | 2007-05-17 | 2016-01-13 | ID Pharma Co., Ltd. | Method for production of dendritic cell |
| EP2176408B9 (en) * | 2008-01-31 | 2015-11-11 | Curevac GmbH | NUCLEIC ACIDS COMPRISING FORMULA (NuGiXmGnNv)a AND DERIVATIVES THEREOF AS AN IMMUNOSTIMULATING AGENTS /ADJUVANTS |
| CN104039952A (zh) * | 2011-11-22 | 2014-09-10 | 塔夫茨大学信托人 | 用于树突状细胞癌症疫苗的小分子增强剂 |
-
2012
- 2012-11-15 CN CN201280067478.5A patent/CN104039952A/zh active Pending
- 2012-11-15 EP EP12850873.6A patent/EP2782994B1/en active Active
- 2012-11-15 CA CA2856379A patent/CA2856379A1/en not_active Abandoned
- 2012-11-15 US US14/353,408 patent/US9284337B2/en active Active
- 2012-11-15 AU AU2012340887A patent/AU2012340887A1/en not_active Abandoned
- 2012-11-15 CN CN201610493117.7A patent/CN106075450A/zh active Pending
- 2012-11-15 HK HK15102280.8A patent/HK1201871A1/xx unknown
- 2012-11-15 JP JP2014543501A patent/JP6240083B2/ja active Active
- 2012-11-15 EP EP16180971.0A patent/EP3106173A1/en not_active Withdrawn
- 2012-11-15 WO PCT/US2012/065236 patent/WO2013078059A1/en not_active Ceased
-
2014
- 2014-05-18 IL IL232664A patent/IL232664A0/en unknown
-
2015
- 2015-11-23 US US14/948,777 patent/US9839646B2/en active Active
-
2017
- 2017-08-22 JP JP2017159116A patent/JP2017214420A/ja active Pending
- 2017-11-20 US US15/817,754 patent/US20180092933A1/en not_active Abandoned
-
2018
- 2018-06-25 AU AU2018204591A patent/AU2018204591A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017214420A5 (https=) | ||
| JP2014533727A5 (https=) | ||
| JP7355758B2 (ja) | ケモカイン受容体調節剤及びその使用 | |
| US10106581B2 (en) | Cyclic peptidomimetic compounds as immunomodulators | |
| KR102566924B1 (ko) | 케모카인 수용체 조절제 및 이의 용도 | |
| ES2539603T3 (es) | Agente inductor de inmunidad | |
| US9776978B2 (en) | 1,3,4-oxadiazole and 1,3,4-thiadiazole derivatives as immunomodulators | |
| US9839646B2 (en) | Small molecule enhancer for dendritic cell cancer vaccines | |
| JP2017536344A5 (https=) | ||
| JP2017519753A5 (https=) | ||
| JP2020508310A5 (https=) | ||
| JP2019512478A5 (https=) | ||
| JP2016534059A5 (https=) | ||
| JP2018504379A5 (https=) | ||
| JP2016514103A5 (ja) | 細胞結合剤及び細胞毒性剤としてのマイタンシノイドを含む複合体 | |
| JP2016519062A5 (https=) | ||
| CN111918652A (zh) | 用于治疗eb病毒阳性的癌症的趋化因子受体调节剂 | |
| JP5201995B2 (ja) | ジアザベンゾ［デ］アントラセン−３−オン化合物、及び、ｐａｒｐの阻害方法 | |
| JP2018516994A5 (https=) | ||
| CN1516600A (zh) | 用于治疗肿瘤疾病的联合药物 | |
| JP2005508857A5 (https=) | ||
| JP2014532751A5 (https=) | ||
| KR102275112B1 (ko) | 5-브로모-인디루빈 | |
| TWI796326B (zh) | 含有ａｘｌ抑制劑與ｅｇｆｒ酪胺酸激酶抑制藥的醫藥品及其用途 | |
| JP2017509672A5 (https=) |